Executive and Scientific Director of Qaujigiartiit Health Research Centre in Iqaluit, NU.
Territorial Chief of Staff in the Department of Health of the Government of Nunavut in Iqaluit.
Can Fam Physician. 2018 Mar;64(3):e108-e114.
To investigate whether the fetal fibronectin assay would be useful for determining if a woman was close to a term delivery. If effective, this test would allow parturient women to stay in their communities longer.
This feasibility study used a prospective cohort design to examine the negative predictive value of the fetal fibronectin test at term.
Iqaluit, NU.
A total of 30 parturient women from rural and isolated communities in Nunavut.
Starting at 36 weeks' gestation, women were tested every 2 days, and after 39 weeks this increased to every day until labour.
The negative predictive value of the fetal fibronectin test was assessed.
Women were no more likely to give birth at 7 or more days after their last negative fetal fibronectin test result relative to their likelihood of giving birth at 6 or fewer days after their last negative test result. Hence, the presence of fetal fibronectin in cervical secretion did not predict term delivery.
This project indicated that the fetal fibronectin test did not have adequate sensitivity or specificity as a diagnostic measure to predict a delay of labour at term.
探讨胎儿纤维连接蛋白检测是否可用于确定孕妇是否即将足月分娩。如果有效,该检测将使产妇能够在社区中停留更长时间。
本可行性研究采用前瞻性队列设计,以检查足月时胎儿纤维连接蛋白检测的阴性预测值。
努纳武特地区伊卡卢伊特。
来自努纳武特农村和偏远社区的 30 名产妇。
从 36 孕周开始,每 2 天检测一次,39 孕周后增加至每天检测一次,直至分娩。
评估胎儿纤维连接蛋白检测的阴性预测值。
与最后一次阴性检测结果后 6 天内分娩的可能性相比,最后一次阴性胎儿纤维连接蛋白检测结果后 7 天或以上分娩的可能性没有增加。因此,宫颈分泌物中存在胎儿纤维连接蛋白并不能预测足月分娩。
本研究表明,胎儿纤维连接蛋白检测作为一种诊断措施,其灵敏度或特异性不足以预测足月分娩的延迟。